Teresa Tarrago

Barcelona Science Park
Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia.

Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia.

Journal: International journal of molecular sciences

Published: November 29, 2022

Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds.

Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds.

Journal: Scientific reports

Published: September 14, 2021

Publisher Correction: Voices of biotech leaders.

Publisher Correction: Voices of biotech leaders.

Journal: Nature biotechnology

Published: July 22, 2021

Voices of biotech leaders.

Voices of biotech leaders.

Journal: Nature biotechnology

Published: June 11, 2021

The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.

The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.

Journal: The Journal of clinical investigation

Published: March 20, 2020

Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors.

Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors.

Journal: Bioorganic chemistry

Published: June 17, 2019

Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.

Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.

Journal: Biochimica et biophysica acta. Biomembranes

Published: January 20, 2019

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.

Journal: Cell chemical biology

Published: February 01, 2018

The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.

The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: June 22, 2016

Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics.

Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics.

Journal: Chembiochem : a European journal of chemical biology

Published: February 19, 2016

The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia.

The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia.

Journal: Schizophrenia research

Published: December 01, 2015

Analyzing slowly exchanging protein conformations by ion mobility mass spectrometry: study of the dynamic equilibrium of prolyl oligopeptidase.

Analyzing slowly exchanging protein conformations by ion mobility mass spectrometry: study of the dynamic equilibrium of prolyl oligopeptidase.

Journal: Journal of mass spectrometry : JMS

Published: November 20, 2015

Showing 1-12 of 25

Last Updated: 09/26/2026